<DOC>
<DOCNO>EP-0624086</DOCNO> 
<TEXT>
<INVENTION-TITLE>
COSMETIC COMPOSITION FOR ADDING TO BATH WATER
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K892	A61K846	A61K864	A61K806	A61K837	A61K889	A61K814	A61K844	A61K872	A61K830	A61K800	A61K814	A61K892	A61K840	A61K800	A61K834	A61K839	A61K804	A61K831	A61K841	A61K896	A61K842	A61K8891	A61K886	A61Q1910	A61K897	A61K804	A61Q1910	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61Q	A61K	A61K	A61Q	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61Q19	A61K8	A61K8	A61Q19	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
OREAL
</APPLICANT-NAME>
<APPLICANT-NAME>
L'OREAL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
HANSENNE-RICHOUX ISABELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
MAURIN VERONIQUE
</INVENTOR-NAME>
<INVENTOR-NAME>
HANSENNE-RICHOUX, ISABELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
MAURIN, VERONIQUE
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Cosmetic skin care composition for adding to bath 
water, comprising, in an aqueous dispersion phase, a 

dispersion of vesicles, the membrane of which consists of 
a lipid phase containing at least one ionic amphiphilic 

lipid and/or at least one non-ionic amphiphilic lipid, 
characterized in that the aqueous dispersion phase 

contains at least one compound of formula 

 
in which formula R is a linear or branched C₂-C₃ alkylene 

radical, R' and R'', which may be identical or different, 
are H or a C₁-C₄ alkyl radical and n is an integer between 

1 and 3 inclusively, the weight ratio between the lipid 
phase of the vesicles and (all of) the compound(s) of 

formula (I) contained in the dispersion phase being 
between 0.25 and 2.5. 
Composition according to Claim 1, characterized 
in that the lipid phase constituting the vesicle membrane 

represents from 1 to 16% by weight relative to the total 
weight of the composition. 
Composition according to either of Claims 1 and 

2, characterized in that the lipid membrane of the 
vesicles encapsulates an aqueous phase which contains at 

least one compound of formula (I). 
Composition according to one of Claims 1 to 3, 
characterized in that the weight ratio between the lipid 

phase and the compound(s) of formula (I) is between 0.5 
and 1.5. 
Composition according to one of Claims 1 to 4, 
characterized in that it contains from 0.5 to 20% by 

weight of compound(s) of formula (I) relative to the 
total weight of the composition. 
Composition according to one of Claims 1 to 5, 
characterized in that the compounds of formula (I) are 

chosen from the group formed by ethylene glycol, diethylene 
glycol, propylene glycol, dipropylene glycol, the 

monomethyl, monoethyl and monobutyl ethers of ethylene  
 

glycol and of diethylene glycol, and the monomethyl 
ethers of propylene glycol and of dipropylene glycol. 
Composition according to one of Claims 1 to 6, 
characterized in that the non-ionic lipid(s) is (are) 

chosen from the group formed by: 

(1) linear or branched polyglycerol derivatives, of 
formula 


 
in which formula (II): 


-C₃H₅(OH)O- is represented by the following structures 
taken as a mixture or separately:
 
-CH₂CHOHCH₂O- , 


n
 is an average statistical value between 1 and 6; 
R° represents: 

(a) a saturated or unsaturated linear or branched 
aliphatic chain containing from 12 to 30 carbon atoms; or 

hydrocarbon radicals of lanolin alcohols; or long-chain 
alpha-diol residues; 
(b) a residue R¹CO, where R¹ is a linear or branched 
C₁₁-C₂₉ aliphatic radical; 
(c) a residue
 
R₂[OC₂H₃(R₃)]
 
where: 


R² may take the meaning (a) or (b) given for R°; 
-OC₂H₃(R³)-
 
is represented by the following structures, taken as a 

mixture or separately:  
 


 
where R³ takes the meaning (a) given for R°; 
(2) linear or branched polyglycerol ethers containing two 
fatty chains; 
(3) polyoxyethylenated fatty alcohols and polyoxyethylenated 
phytosterols and sterols; 
(4) polyol ethers; 
(5) oxyethylenated or non-oxyethylenated polyol esters; 
(6) glycolipids of natural or synthetic origin and in 
particular glucose ethers and esters; 
(7) hydroxy amides represented by the formula: 

 
in which formula (III): 


R⁴ denotes a C₇-C₂₁ alkyl or alkenyl radical; 
R⁵ denotes a C₇-C₃₁ saturated or unsaturated hydrocarbon 
radical; 
COA denotes a group chosen from the following two 
groups: 


a residue 

 
where: 


B is an alkyl radical derived from mono- or 
polyhydroxylated primary or secondary amines; and 
R⁶ denotes a hydrogen atom or a methyl, ethyl 
or hydroxyethyl radical; and 
a residue -COOZ, where Z represents a C₃-C₇ polyol 
residue; 
(8) the glycerol derivatives corresponding to the  
 

formula: 

 
in which formula (IV) R₇ represents a linear C₁₄-C₁₈ alkyl 

radical or a group -CH₂A in which A is -OR₁₄, R₁₄ representing 
a linear C₁₀ to C₁₈ alkyl radical, and n represents 

either an average statistical value greater than 1 and at 
least equal to 3, or alternatively, when R₇ represents 

-CH₂A, a value equal to 2. 
Composition according to one of Claims 1 to 7, 
characterized in that the anionic amphiphilic lipid(s) is 

(are) chosen from the group formed by: 

natural phospholipids, phospholipids modified via 
a chemical or enzymatic route, and synthetic phospholipids, 
anionic compounds of formula 

 
in which formula (V): 


R₈ represents a C₇-C₂₁ alkyl or alkenyl radical 
R₉ represents a saturated or unsaturated C₇-C₃₁ 
hydrocarbon radical, and 
M represents H, Na, K, NH₄ or a substituted 
ammonium ion derived from an amine, 
gangliosides, 
cationic compounds having the formula: 

 
with R₁₀ and R₁₁, which may be identical or different,  

 
representing C₁₂ - C₂₀ alkyl radicals and R₁₂ and R₁₃, which 

may be identical or different, representing C₁ - C₄ alkyl 
radicals; and 
polymerizable lipids. 
Composition according to one of Claims 1 to 8, 
characterized in that the lipid phase constituting the 

vesicle membrane contains at least one stabilizing 
additive having the function of decreasing the permeability 

of the vesicle membrane and/or of improving the 
stability of the vesicles. 
Composition according to Claim 9, characterized 
in that the stabilizing additive is chosen from the group 

formed by: 

sterols and their derivatives, 
long-chain alcohols and diols, 
long-chain amines and quaternary ammonium derivatives 
thereof, 
dihydroxyalkylamines, polyoxyethylenated fatty amines; 
esters of long-chain amino alcohols and salts and 

quaternary ammonium derivatives thereof, 
phosphoric esters of fatty alcohols, 
alkyl sulphates, 
polypeptides and proteins. 
Composition according to one of Claims 1 to 10, 
characterized in that the lipid phase constituting the 

vesicle membrane contains from 1 to 80% by weight of 
amphiphilic lipid(s). 
Composition according to one of Claims 1 to 11, 
characterized in that the aqueous dispersion phase 

contains a dispersion of droplets of at least one water-immiscible 
compound which are stabilized by the lipid 

vesicles. 
Composition according to one of Claims 1 to 12, 
characterized in that it contains at least one cosmetically 

acceptable additive chosen from the group formed by 
silicone oils, oxyethylenated and non-oxyethylenated 

mineral and vegetable oils, natural and synthetic essential 
oils, fatty acid esters, mono-, di- and
 triglycerides 
of long-chain fatty acids, C₂-C₆ polyols, moisturizing  

 
agents, polymers, preservatives, perfumes, acidifying 

and basifying agents, stabilizers and colouring agents. 
Composition according to one of Claims 1 to 13, 
characterized in that it contains from 0.5 to 15% by 

weight of ionic and/or non-ionic amphiphilic lipid(s) 
relative to the total weight of the composition. 
Composition according to Claim 9, characterized 
in that the stabilizing additive of the lipid phase 

represents less than 8% by weight relative to the total 
weight of the composition. 
Composition according to one of Claims 1 to 15, 
characterized in that the vesicles have an average 

diameter between 10 and 1,000 nm. 
Composition according to one of Claims 1 to 16, 
characterized in that its viscosity is between 20 and 

100 Pa.s. 
Process for the manufacture of a composition 
according to one of Claims 1 to 17, characterized in 

that, in a first step, a dispersion of vesicles in an 
aqueous dispersion phase is prepared and in that, in a 

second step, at least one compound of formula (I) is 
added to the said aqueous dispersion phase. 
</CLAIMS>
</TEXT>
</DOC>
